Correct!
Rationale: p53 is a tumour suppressor protein that plays a key role in promoting apoptosis in response to cellular stress and DNA damage. A mutation in p53 can allow cancer cells to evade apoptosis, directly affecting the hallmark of “Resisting cell death.”
A researcher is developing a therapeutic agent that inhibits the function of vascular endothelial growth factor (VEGF). Which of the following outcomes would most likely result from the successful application of this agent in cancer treatment?
